CellaVision AB
OTC:CLVSF

Watchlist Manager
CellaVision AB Logo
CellaVision AB
OTC:CLVSF
Watchlist
Price: 17.3 USD Market Closed
Market Cap: $412.6m

Gross Margin

69.1%
Current
Improving
by 1%
vs 3-y average of 68.1%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
69.1%
=
Gross Profit
kr517.3m
/
Revenue
kr748.5m

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
69.1%
=
Gross Profit
$517.3m
/
Revenue
kr748.5m

Peer Comparison

Country Company Market Cap Gross
Margin
SE
CellaVision AB
STO:CEVI
3.6B SEK
Loading...
US
Abbott Laboratories
NYSE:ABT
184.5B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.3B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
136.2B USD
Loading...
US
Stryker Corp
NYSE:SYK
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
129B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
57.4B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.3B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
46.8B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.4B USD
Loading...

Market Distribution

Higher than 73% of companies in Sweden
Percentile
73rd
Based on 1 864 companies
73rd percentile
69.1%
Low
-855 316.7% — 30.8%
Typical Range
30.8% — 66%
High
66% — 113 764.6%
Distribution Statistics
Sweden
Min -855 316.7%
30th Percentile 30.8%
Median 44.8%
70th Percentile 66%
Max 113 764.6%

CellaVision AB
Glance View

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CLVSF Intrinsic Value
HIDDEN
Show
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
69.1%
=
Gross Profit
kr517.3m
/
Revenue
kr748.5m
What is CellaVision AB's current Gross Margin?

The current Gross Margin for CellaVision AB is 69.1%, which is above its 3-year median of 68.1%.

How has Gross Margin changed over time?

Over the last 3 years, CellaVision AB’s Gross Margin has decreased from 69.3% to 69.1%. During this period, it reached a low of 66.6% on Jun 30, 2024 and a high of 69.3% on Sep 30, 2022.

Back to Top